146 related articles for article (PubMed ID: 15544619)
1. Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats.
Morgan BP; Griffiths M; Khanom H; Taylor SM; Neal JW
Clin Exp Immunol; 2004 Dec; 138(3):430-8. PubMed ID: 15544619
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte effects of C5a-receptor blockade during simulated extracorporeal circulation.
Rinder CS; Smith MJ; Rinder HM; Cortright DN; Brodbeck RM; Krause JE; Smith BR
Ann Thorac Surg; 2007 Jan; 83(1):146-52. PubMed ID: 17184649
[TBL] [Abstract][Full Text] [Related]
3. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
4. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis.
Piddlesden SJ; Storch MK; Hibbs M; Freeman AM; Lassmann H; Morgan BP
J Immunol; 1994 Jun; 152(11):5477-84. PubMed ID: 8189065
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats.
Arumugam TV; Woodruff TM; Stocks SZ; Proctor LM; Pollitt S; Shiels IA; Reid RC; Fairlie DP; Taylor SM
J Hepatol; 2004 Jun; 40(6):934-41. PubMed ID: 15158333
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.
Strachan AJ; Shiels IA; Reid RC; Fairlie DP; Taylor SM
Br J Pharmacol; 2001 Dec; 134(8):1778-86. PubMed ID: 11739255
[TBL] [Abstract][Full Text] [Related]
7. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.
Proctor LM; Arumugam TV; Shiels I; Reid RC; Fairlie DP; Taylor SM
Br J Pharmacol; 2004 Jun; 142(4):756-64. PubMed ID: 15159277
[TBL] [Abstract][Full Text] [Related]
8. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
Thrane AS; Skehan JD; Thrane PS
Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
[TBL] [Abstract][Full Text] [Related]
9. Human T cells express the C5a receptor and are chemoattracted to C5a.
Nataf S; Davoust N; Ames RS; Barnum SR
J Immunol; 1999 Apr; 162(7):4018-23. PubMed ID: 10201923
[TBL] [Abstract][Full Text] [Related]
10. Immunization with a cannabinoid receptor type 1 peptide results in experimental allergic meningocerebellitis in the Lewis rat: a model for cell-mediated autoimmune neuropathology.
Proescholdt MG; Quigley L; Martin R; Herkenham M
J Neurosci Res; 2002 Oct; 70(2):150-60. PubMed ID: 12271464
[TBL] [Abstract][Full Text] [Related]
11. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
Bao L; Osawe I; Puri T; Lambris JD; Haas M; Quigg RJ
Eur J Immunol; 2005 Aug; 35(8):2496-506. PubMed ID: 16052609
[TBL] [Abstract][Full Text] [Related]
12. Systemic blockade of complement C5a receptors reduces lipopolysacharride-induced responses in the paraventricular nucleus and the central amygdala.
Crane JW; Buller KM
Neurosci Lett; 2007 Aug; 424(1):10-5. PubMed ID: 17703884
[TBL] [Abstract][Full Text] [Related]
13. [Complement activation and inflammation].
Abe M
Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
[TBL] [Abstract][Full Text] [Related]
14. Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist.
Sewell DL; Nacewicz B; Liu F; Macvilay S; Erdei A; Lambris JD; Sandor M; Fabry Z
J Neuroimmunol; 2004 Oct; 155(1-2):55-63. PubMed ID: 15342196
[TBL] [Abstract][Full Text] [Related]
15. The complement system in central nervous system diseases.
Rus H; Cudrici C; David S; Niculescu F
Autoimmunity; 2006 Aug; 39(5):395-402. PubMed ID: 16923539
[TBL] [Abstract][Full Text] [Related]
16. Oral treatment with complement factor C5a receptor (CD88) antagonists inhibits experimental periodontitis in rats.
Breivik T; Gundersen Y; Gjermo P; Taylor SM; Woodruff TM; Opstad PK
J Periodontal Res; 2011 Dec; 46(6):643-7. PubMed ID: 21722134
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine.
Arumugam TV; Shiels IA; Woodruff TM; Reid RC; Fairlie DP; Taylor SM
J Surg Res; 2002 Apr; 103(2):260-7. PubMed ID: 11922743
[TBL] [Abstract][Full Text] [Related]
18. Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis.
Michailidou I; Jongejan A; Vreijling JP; Georgakopoulou T; de Wissel MB; Wolterman RA; Ruizendaal P; Klar-Mohamad N; Grootemaat AE; Picavet DI; Kumar V; van Kooten C; Woodruff TM; Morgan BP; van der Wel NN; Ramaglia V; Fluiter K; Baas F
Acta Neuropathol Commun; 2018 May; 6(1):36. PubMed ID: 29724241
[TBL] [Abstract][Full Text] [Related]
19. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation.
Tschernig T; Kiafard Z; Dibbert C; Neumann D; Zwirner J
Exp Toxicol Pathol; 2007 Aug; 58(6):419-25. PubMed ID: 17544263
[TBL] [Abstract][Full Text] [Related]
20. Complement inhibition keeps mothers calm and avoids fetal rejection.
Girardi G
Immunol Invest; 2008; 37(5):645-59. PubMed ID: 18716942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
